FDA Warns Cosmetics Co. on Possible Seizure, Etc. for FFDCA Marketing Violation
The Food and Drug Administration has issued a warning letter to Refine USA, LLC regarding its marketing of the VeinGogh Ohmic Thermolysis System without marketing clearance or approval, in violation of the Federal Food, Drug, and Cosmetic Act. FDA states…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
that failure to promptly correct the violations may result in regulatory action being initiated, including, but not limited to, seizure, injunction, and/or civil penalties.